ARIZ ANKLESARIA: Open Payments
NPI 1538314398 · TROY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,854 in 237 payments from 15 companies in 2025. Trend: 2023 $3,345 · 2024 $3,236 · 2025 $4,854
Food & beverage: $3,601Travel & lodging: $1,245Education: $8
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 31 | $1,811 |
| Otsuka America Pharmaceutical, Inc. | 46 | $639 |
| Vanda Pharmaceuticals Inc. | 26 | $496 |
| Lundbeck LLC | 27 | $421 |
| ABBVIE INC. | 29 | $353 |
| Axsome Therapeutics, Inc. | 13 | $270 |
| E.R. Squibb & Sons, L.L.C. | 25 | $269 |
| Alkermes, Inc. | 20 | $245 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $144 |
| Teva Pharmaceuticals USA, Inc. | 4 | $80 |
Products named: SPRAVATO, REXULTI, HETLIOZ, VRAYLAR, ABILIFY MAINTENA, Auvelity, COBENFY, ARISTADA.
Industry payments across OH — which companies pay providers there.
